Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Workspace warns on profits, shares slide

(Sharecast News) - Office landlord Workspace Group warned on profits on Friday, sending the shares sharply lower, on the back of higher costs and mounting macroeconomic pressures. Updating investors ahead of publishing full-year results, the flexible workspace provider - which manages around 4.2m sq ft of space in London and the south east - confirmed trading profits for the year to 31 March 2025 would be line with consensus.

But it also flagged a decline in occupancy and a "marginal" fall in valuation, due to reduced estimated rental value per sq ft, and warned of profit headwinds in the current year.

In particular, the real estate investment trust said "several factors" would impact the year to March 2026, including a lower opening rent roll, further large unit vacations and higher costs, including employers' National Insurance contributions and refinancing costs.

As a result, it now expects a £7m hit to profits. Consensus is currently for 2026 trading profits of between £66m and £72m.

As at 0845 BST, the FTSE 250 stock was trading 10% lower at 408.07p.

Workspace said it would now focus on implementing a recently agreed strategic plan, which was intended to "drive a recovery in occupancy and income growth in the medium term.

"We will also demonstrate how we will deliver longer-term shareholder value through a strategy anchored in operational excellence.

"This disciplined approach will drive enhancements to the platform, investment in our product and more targeted marketing initiatives to support customer growth and increase market share."

Further details will be published alongside the results, on 5 June.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.